When Should Myeloma Risk Be Assessed? Can Risk Status Change Over Time? скачать в хорошем качестве

When Should Myeloma Risk Be Assessed? Can Risk Status Change Over Time?

#HTUmyeloma Risk stratification in multiple myeloma (MM) is crucial for tailoring treatment, predicting outcomes, and guiding clinical decisions. It's used to identify high-risk patients who may benefit from more aggressive therapies or clinical trials, while also allowing for a more targeted approach to management for those at lower (standard) risk. This HealthTree University lessons explains when risk stratification should be done and how risk may change over time. Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer! Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_so... Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.